Composition
Zoledronic Acid Infusion
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Zoledoberg contains Zoledronic Acid, a potent bisphosphonate that inhibits osteoclast-mediated bone resorption for annual osteoporosis treatment.
Indication
Osteoporosis, Paget's disease of bone, and prevention of skeletal events in malignancy-related bone disease.
Packaging
100 ml poly pack
Storage
Store below 25°C, protected from light. Use reconstituted solution as directed.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.